P10, Inc. (NYSE: PX) has recently made some significant changes by appointing Jennifer Glassman and Stephen Blewitt to its Board of Directors. The company has expressed excitement about this new development, emphasizing the proven track records and expertise that both Glassman and Blewitt bring to the table, which is expected to strengthen the board and enhance the company's governance profile.
Jennifer Glassman, the newly appointed independent Class I director, currently serves as the Chief Financial Officer of Towerbrook Capital Partners. She has held significant financial leadership roles in the past, including as a partner and CFO at Soros Private Equity, and has a strong background in financial control and reporting.
Stephen Blewitt, on the other hand, joins the Board as an independent Class III director. He is the co-founder of Youth.Work.Connect and has previously served as the Chief Investment Officer (Private Markets) and Head of Private Markets at Manulife Investment Management. With extensive experience leading global investment teams across various asset classes, including private equity and credit, real estate, infrastructure, timber, and agriculture, Blewitt's appointment is expected to bring valuable expertise to the Compensation Committee.
P10 is a leading multi-asset class private markets solutions provider with a global investor base of more than 3,800 investors across 50 states, 60 countries, and six continents. The company's mission is to provide its investors with differentiated access to a broad set of investment solutions within private markets.
The addition of Glassman and Blewitt to the Board of Directors is a strategic move by P10, aiming to create long-term value for its investment strategies and shareholders. As the company continues to evolve, these new appointments are poised to play a crucial role in shaping its future direction and governance.
For more information about P10, visit www.p10alts.com. Following these announcements, the company's shares moved 2.0%, and are now trading at a price of $10.61. For more information, read the company's full 8-K submission here.